Agouron Pharmaceuticals (AGPH) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bhag Karamchandani who wrote (4623)	6/29/1998 11:55:00 PM
From: scaram(o)uche	Read Replies (1) of 6136

>> Life cycle for any of these drugs is hard to predict- except that it is increasingly shrinking or appears to be threatened << "Appears" doesn't count. Increasingly shrinking? The very first drug for AIDS, AZT, is still widely in use. Even rit is still alive. To which example are you pointing? >> I would prefer AGPH to have two legs ( if not three) but one leg is inherently unstable << Which PI is superior to Viracept? >> I am disappointed that AGPH has not provided additional info on the AG 3340 trials - conducted and in progress << Tommysdad and others have dealt with the phase I issues for you. The phase II/III testing has just started, and it is blinded. What sort of information would you like? Trial design? Sufficient detail has been given, IMO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next